CompoAtlas

BluVision Eye bright essentials

Natural health product licensed in Canada

Licence holder
BC Blueberry Biotechnology Co. Ltd.
NPN or DIN-HM
80068850
Status
Inactive licence
Licence date
25 April 2016
Revision date
Not provided
Form
Poudre pour solution
Route of administration
Orale
Application type
Officinale

If this product were sold in France

No point flagged by the rules we apply.

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Lutéine

Source : Tagetes erecta - Fleur

12 milligrammeNot calculated
Vaccinium angustifolium

Source : Fruit

Extract : Matériel brut frais

Extraction ratio : 250:1

Dry plant equivalent : 25 Grammes

Potency : 36 % Anthocyanins

100 milligrammeNot calculated
Vaccinium myrtillus

Source : Fruit

Extract : Matériel brut frais

Extraction ratio : 250:1

Dry plant equivalent : 25 Grammes

Potency : 36 % Anthocyanins

100 milligrammeNot calculated
Ipomoea batatas

Source : Tubercule

Extract : Matériel brut frais

Extraction ratio : 100:1

Dry plant equivalent : 25 Grammes

250 milligrammeNot calculated

Non-medicinal ingredients

Extrait de fruit de monk, Feuille de Stevia rebaudiana, Sucrose, Acide citrique, Gomme arabique, Saveur de bleuet, Dioxyde de silicium

PopulationAgeQuantity per servingFrequency
AdultesNot specified1 Portion(s)minimum: 1 Tous les jours ; maximum: 2 Tous les jours

Uses authorised in Canada

Provides antioxidants that help protect cell against the oxidative damage caused by free radicals. Helps to maintain eyesight in conditions, such as cataracts and age-related macular degeneration. Helps to slow the progression of diabetic and hypertensive retinopathy.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

Source

Official Health Canada record, licence 80068850

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line